1. Home
  2. Clinical Topics
  3. FDA approves new melanoma treatments
Clinical TopicsDrugs and DevicesNewsWeb Exclusives

FDA approves new melanoma treatments

Share
  • On Oct. 28, the U.S. Food and Drug Administration (FDA) expanded the approved use of Yervoy (ipilimumab) to include a new use as adjuvant therapy for patients with stage III melanoma, to lower the risk that the melanoma will return following surgery. Read more.
  • On Oct. 27, the FDA approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the skin and lymph nodes. Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Menu